Skip to main content Back to Top
Advertisement

6/10/2022

Losartan Tablets

Products Affected - Description

    • Losartan potassium oral tablet, Alembic, 100 mg, bottle, 30 count, NDC 62332-0029-30
    • Losartan potassium oral tablet, Alembic, 100 mg, bottle, 90 count, NDC 62332-0029-90
    • Losartan potassium oral tablet, Alembic, 100 mg, bottle, 1000 count, NDC 62332-0029-91
    • Losartan potassium oral tablet, Alembic, 25 mg, bottle, 30 count, NDC 62332-0027-30
    • Losartan potassium oral tablet, Alembic, 25 mg, bottle, 90 count, NDC 62332-0027-90
    • Losartan potassium oral tablet, Alembic, 25 mg, bottle, 1000 count, NDC 62332-0027-91
    • Losartan potassium oral tablet, Alembic, 50 mg, bottle, 30 count, NDC 62332-0028-30
    • Losartan potassium oral tablet, Alembic, 50 mg, bottle, 90 count, NDC 62332-0028-90
    • Losartan potassium oral tablet, Alembic, 50 mg, bottle, 1000 count, NDC 62332-0028-91
    • Losartan potassium oral tablet, Cadista, 100 mg, bottle, 30 count, NDC 59746-0335-30
    • Losartan potassium oral tablet, Cadista, 100 mg, bottle, 90 count, NDC 59746-0335-90
    • Losartan potassium oral tablet, Cadista, 100 mg, bottle, 1000 count, NDC 59746-0335-10
    • Losartan potassium oral tablet, Cadista, 25 mg, bottle, 90 count, NDC 59746-0333-90
    • Losartan potassium oral tablet, Cadista, 25 mg, bottle, 1000 count, NDC 59746-0333-10
    • Losartan potassium oral tablet, Cadista, 50 mg, bottle, 30 count, NDC 59746-0334-30
    • Losartan potassium oral tablet, Cadista, 50 mg, bottle, 90 count, NDC 59746-0334-90
    • Losartan potassium oral tablet, Cadista, 50 mg, bottle, 1000 count, NDC 59746-0334-10
    • Losartan potassium oral tablet, Camber, 100 mg, bottle, 30 count, NDC 31722-0702-30
    • Losartan potassium oral tablet, Camber, 100 mg, bottle, 90 count, NDC 31722-0702-90
    • Losartan potassium oral tablet, Camber, 100 mg, bottle, 1000 count, NDC 31722-0702-10
    • Losartan potassium oral tablet, Camber, 25 mg, bottle, 90 count, NDC 31722-0700-90
    • Losartan potassium oral tablet, Camber, 25 mg, bottle, 1000 count, NDC 31722-0700-10
    • Losartan potassium oral tablet, Camber, 50 mg, bottle, 30 count, NDC 31722-0701-30
    • Losartan potassium oral tablet, Camber, 50 mg, bottle, 90 count, NDC 31722-0701-90
    • Losartan potassium oral tablet, Camber, 50 mg, bottle, 1000 count, NDC 31722-0701-10
    • Losartan potassium oral tablet, Lupin, 100 mg, bottle, 90 count, NDC 68180-0378-09
    • Losartan potassium oral tablet, Lupin, 100 mg, bottle, 1000 count, NDC 68180-0378-03
    • Losartan potassium oral tablet, Lupin, 25 mg, bottle, 90 count, NDC 68180-0376-09
    • Losartan potassium oral tablet, Lupin, 25 mg, bottle, 1000 count, NDC 68180-0376-03
    • Losartan potassium oral tablet, Lupin, 50 mg, bottle, 90 count, NDC 68180-0377-09
    • Losartan potassium oral tablet, Lupin, 50 mg, bottle, 1000 count, NDC 68180-0377-03
    • Losartan potassium oral tablet, Zydus, 100 mg, bottle, 30 count, NDC 68382-0137-06
    • Losartan potassium oral tablet, Zydus, 100 mg, bottle, 90 count, NDC 68382-0137-16
    • Losartan potassium oral tablet, Zydus, 25 mg, bottle, 30 count, NDC 68382-0135-06
    • Losartan potassium oral tablet, Zydus, 50 mg, bottle, 30 count, NDC 68382-0136-06
    • Losartan potassium oral tablet, Zydus, 50 mg, bottle, 90 count, NDC 68382-0136-16
    • Losartan potassium oral tablet, Zydus, 50 mg, bottle, 1000 count, NDC 68382-0136-10

Reason for the Shortage

    • Beginning in mid-2018, FDA found that several angiotensin II receptor blocker (ARB) medicines contained nitrosamine impurities and have been recalled because they do not meet FDA's safety standards. Additional information including a list of affected lots can be found at https://www.fda.gov/drugs/drug-safety-and-availability/recalls-angiotensin-ii-receptor-blockers-arbs-including-valsartan-losartan-and-irbesartan.
    • Camber, Avet, Teva, and Torrent were affected by the recall.
    • Alembic did not provide a reason for the shortage.
    • Aurobindo refuses to provide updated availability information.
    • Avet discontinued losartan tablets in 2021.
    • Cadista has temporarily discontinued losartan tablets due to issues with obtaining active ingredient.
    • Camber did not provide a reason for the shortage.
    • Lupin did not provide a reason for the shortage.
    • Major did not provide a reason for the shortage.
    • Merck divested Cozaar to Organon. Their NDCs were changed in late-2021.
    • Organon has Cozaar available.
    • Torrent discontinued losartan tablets in late-2021.
    • Zydus did not provide a reason for the shortage.

Available Products

    • Cozaar oral tablet, Organon, 100 mg, bottle, 30 count, NDC 78206-0123-01
    • Cozaar oral tablet, Organon, 100 mg, bottle, 90 count, NDC 78206-0123-02
    • Cozaar oral tablet, Organon, 25 mg, bottle, 90 count, NDC 78206-0121-01
    • Cozaar oral tablet, Organon, 50 mg, bottle, 30 count, NDC 78206-0122-01
    • Cozaar oral tablet, Organon, 50 mg, bottle, 90 count, NDC 78206-0122-02
    • Losartan potassium oral tablet, Major, 100 mg, unit-dose blister pack, 100 count, NDC 00904-7049-61
    • Losartan potassium oral tablet, Major, 25 mg, unit-dose blister pack, 100 count, NDC 00904-7047-61
    • Losartan potassium oral tablet, Major, 50 mg, unit-dose blister pack, 100 count, NDC 00904-7048-61
    • Losartan potassium oral tablet, Zydus, 100 mg, bottle, 1000 count, NDC 68382-0137-10
    • Losartan potassium oral tablet, Zydus, 25 mg, bottle, 90 count, NDC 68382-0135-16
    • Losartan potassium oral tablet, Zydus, 25 mg, bottle, 1000 count, NDC 68382-0135-10

Estimated Resupply Dates

    • Alembic has all losartan potassium tablet presentations on allocation.
    • Cadista has temporarily discontinued losartan potassium tablets and the company cannot estimate when product will be available again.
    • Camber has losartan 50 mg tablets in 30 count bottles, 50 mg tablets in 1,000 count bottles, and 100 mg tablets in 1,000 count bottles on intermittent back order and the company is releasing supplies as they become available.
    • Lupin has all losartan potassium tablet presentations on back order and the company cannot estimate when product will be available again.
    • Zydus has losartan tablets on allocation.

Updated

Updated June 10, 2022 by Anthony Trovato, PharmD, BCPS. Created June 7, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.